Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
38.89
Jul 15 • 06:46AM ET Dollar change-0.08 Percentage change(-0.21%)
Category
US Equities - Industry Sector
Sponsor
Simplify ETF
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.51%
Inverse/Leveraged
IPO
Oct 08, 2021
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
0.28%
SMA50
3.44%
SMA200
8.67%
Return% 1Y
28.58%
Return% 3Y
15.15%
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
30.97%
Flows% 3M
41.87%
Flows% YTD
4.11%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
55
AUM
378.59M
NAV/sh
52W High
40.41 -3.76%
52W Low
28.32 37.32%
Volatility
1.56% 1.44%
ATR (14)
0.60
RSI (14)
53.94
Beta
0.73
Rel Volume
0.00
Avg Volume
141.96K
Volume
5
Perf Week
-1.77%
Perf Month
4.82%
Perf Quarter
9.21%
Perf Half Y
3.57%
Perf YTD
6.26%
Perf Year
30.24%
Perf 3Y
46.81%
Perf 5Y
-
Perf 10Y
-
Prev Close
38.97
Price
38.89
Change
-0.21%
Mar-09-26 11:47AM
Feb-25-26 01:46AM
Feb-17-26 06:42AM
Jan-29-26 08:20AM
Jan-26-26 08:55AM
10:00AM Loading…
Nov-26-25 10:00AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
01:30PM Loading…
Feb-28-24 01:30PM
Dec-15-23 07:00PM
Oct-31-23 03:00AM
Oct-12-22 09:05AM
May-17-22 08:56AM
Dec-28-21 08:57AM
Simplify Health Care ETF seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 - 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.